CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Returned to the company · Stock Option (right to buy) | −2,199 | 0 | ||
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Returned to the company · Stock Option (right to buy) | −4,759 | 0 | ||
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Returned to the company · Stock Option (right to buy) | −864 | 0 | ||
| 2023-05-31 | Bazemore Todd SEE REMARKS | Grant or award | +21,158 | 35,993 | ||
| 2023-05-31 | Bazemore Todd SEE REMARKS | Returned to the company · Stock Option (right to buy) | −3,439 | 0 | ||
| 2023-05-31 | Bazemore Todd SEE REMARKS | Returned to the company · Stock Option (right to buy) | −499 | 0 | ||
| 2023-05-31 | Bazemore Todd SEE REMARKS | Returned to the company · Stock Option (right to buy) | −3,499 | 0 | ||
| 2023-05-31 | Bazemore Todd SEE REMARKS | Returned to the company · Stock Option (right to buy) | −3,499 | 0 | ||
| 2023-05-31 | Bazemore Todd SEE REMARKS | Returned to the company · Stock Option (right to buy) | −2,400 | 0 | ||
| 2023-05-31 | Bazemore Todd SEE REMARKS | Returned to the company · Stock Option (right to buy) | −2,199 | 0 | ||
| 2023-05-31 | Bazemore Todd SEE REMARKS | Returned to the company · Stock Option (right to buy) | −4,759 | 0 | ||
| 2023-05-31 | Bazemore Todd SEE REMARKS | Returned to the company · Stock Option (right to buy) | −864 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award | +71,715 | 117,681 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −5,449 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −7,576 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −12,195 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −1,572 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −4,599 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −9,199 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −7,299 | 0 |
Page 10 of 12 · 236 trades